Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Olympus ( (JP:7733) ) has issued an update.
Olympus Corporation has announced an additional investment of USD 150 million into its corporate venture capital fund, Olympus Innovation Ventures Fund II. This move is part of Olympus’s strategy to foster innovation and growth by building relationships with early-stage companies and nurturing partnerships with entrepreneurial teams. The investment aims to strengthen Olympus’s portfolio and support its expansion into new market segments, although it is not expected to have a material impact on the company’s financial results for the fiscal year ending March 31, 2026.
The most recent analyst rating on (JP:7733) stock is a Buy with a Yen2317.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation is a global MedTech company focusing on innovation-driven growth, particularly in the field of endoscopy and robotics. The company is committed to expanding into faster-growing segments and enhancing its performance in emerging markets, with a strategic focus on mergers and acquisitions in close adjacencies.
YTD Price Performance: -12.89%
Average Trading Volume: 3,843,760
Technical Sentiment Signal: Buy
Current Market Cap: Yen2250.7B
Learn more about 7733 stock on TipRanks’ Stock Analysis page.